Skip to content
‹ Back to IndustriesHealthcare

At HIMSS 2023, Companies Tackle Physician Burnout With Voice-Based AI

In a time when healthcare professionals confront unparalleled obstacles, a pertinent question in the realm of healthcare is how can doctors be supported in preserving their well-being and efficiency. HIMSS 2023  unveiled cutting-edge healthcare solutions, targeting AI technology and the crucial issue of physician burnout during the COVID-19 pandemic—breakthroughs that could potentially transform the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

In a time when healthcare professionals confront unparalleled obstacles, a pertinent question in the realm of healthcare is how can doctors be supported in preserving their well-being and efficiency. HIMSS 2023 unveiled cutting-edge healthcare solutions, targeting AI technology and the crucial issue of physician burnout during the COVID-19 pandemic—breakthroughs that could potentially transform the healthcare landscape.

HIMSS, in a nutshell, is an event that unites healthcare professionals, innovators, and market suppliers globally to discuss the latest advancements in healthcare technology. With over 1,000 companies attending, topics such as digital health transformation, AI, telehealth, and cybersecurity are explored. In addition, physician burnout, which has been exacerbated drastically by the pandemic, is one of the more critical concerns addressed. In fact, a recent study reveals that burnout rates among US physicians have skyrocketed, with one in five considering leaving their current practice within two years due to stress. HIMSS 2023 aimed to tackle this crisis by featuring Suki, a voice-based digital assistant for doctors. Suki aims to alleviate clinician burnout, allowing doctors to focus on patient care while improving efficiency and cost savings. 

Punit Soni, CEO of Suki, shares how Suki is making healthcare tech-assisted and invisible, enabling doctors to work more efficiently and reduce clinician burnout.

Punit’s Thoughts:

“Great. Well, we are Suki, and we are a voice-based digital assistant for doctors. The biggest public health crisis in the country that very few people talk about is clinician burnout. And what Suki does is actually help doctors to basically focus on clinical care and makes healthcare tech-assisted when invisible so that they can do that.

That’s why we are here, and we are trying to make sure that doctors can find out about us. In today’s world where large language models and all sorts of AI technology is the absolute buzzword, we’ve been doing this for about five or six years.

And the key things about Suki is you can use Suki to dictate, you can use Suki to command and get information about the patient if you want to. You can also use Suki and put it in ‘ambient mode’ so that it can automatically generate notes out of a patient-doctor conversation. And if you like pure software that can actually help you do all of those things and works well with your EHRs, then Suki is the right place to be.”

Article written by: Azam Saghir

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512